Calithera Biosciences CALA
$ 0.37
-10.95%
Quarterly report 2022-Q3
added 11-14-2022
Country |
USA |
IPO year |
2014 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Susan Molineaux |
Employees in the company |
90 |
Shares |
73.9 M |
Market Cap[1] |
$ 876 K |
EBITDA (LTM) |
$ -45.3 M |
P/E (LTM) |
-0.05 |
P/S (LTM) |
0.02 |
EPS (LTM) |
-7.25 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.